• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黄嘌呤氧化还原酶在慢性肾脏病中的新作用

Emerging Roles of Xanthine Oxidoreductase in Chronic Kidney Disease.

作者信息

Korsmo Hunter W, Ekperikpe Ubong S, Daehn Ilse S

机构信息

Department of Medicine, Division of Nephrology, The Icahn School of Medicine at Mount Sinai, One Gustave Levy Place, Box 1243, New York, NY 10029, USA.

出版信息

Antioxidants (Basel). 2024 Jun 12;13(6):712. doi: 10.3390/antiox13060712.

DOI:10.3390/antiox13060712
PMID:38929151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11200862/
Abstract

Xanthine Oxidoreductase (XOR) is a ubiquitous, essential enzyme responsible for the terminal steps of purine catabolism, ultimately producing uric acid that is eliminated by the kidneys. XOR is also a physiological source of superoxide ion, hydrogen peroxide, and nitric oxide, which can function as second messengers in the activation of various physiological pathways, as well as contribute to the development and the progression of chronic conditions including kidney diseases, which are increasing in prevalence worldwide. XOR activity can promote oxidative distress, endothelial dysfunction, and inflammation through the biological effects of reactive oxygen species; nitric oxide and uric acid are the major products of XOR activity. However, the complex relationship of these reactions in disease settings has long been debated, and the environmental influences and genetics remain largely unknown. In this review, we give an overview of the biochemistry, biology, environmental, and current clinical impact of XOR in the kidney. Finally, we highlight recent genetic studies linking and risk for kidney disease, igniting enthusiasm for future biomarker development and novel therapeutic approaches targeting XOR.

摘要

黄嘌呤氧化还原酶(XOR)是一种普遍存在的必需酶,负责嘌呤分解代谢的终末步骤,最终产生尿酸,尿酸由肾脏排出体外。XOR也是超氧阴离子、过氧化氢和一氧化氮的生理来源,这些物质可作为第二信使激活各种生理途径,还会促使包括肾脏疾病在内的慢性疾病的发生和发展,而肾脏疾病在全球的患病率正在上升。XOR活性可通过活性氧的生物学效应促进氧化应激、内皮功能障碍和炎症反应;一氧化氮和尿酸是XOR活性的主要产物。然而,这些反应在疾病背景下的复杂关系长期以来一直存在争议,其环境影响和遗传学因素在很大程度上仍不清楚。在这篇综述中,我们概述了XOR在肾脏中的生物化学、生物学、环境因素以及当前的临床影响。最后,我们重点介绍了将XOR与肾脏疾病风险联系起来的近期遗传学研究,这激发了人们对未来生物标志物开发以及针对XOR的新型治疗方法的热情。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/489f/11200862/837065d7ef3c/antioxidants-13-00712-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/489f/11200862/12debcf6166c/antioxidants-13-00712-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/489f/11200862/c86d94c3baad/antioxidants-13-00712-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/489f/11200862/837065d7ef3c/antioxidants-13-00712-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/489f/11200862/12debcf6166c/antioxidants-13-00712-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/489f/11200862/c86d94c3baad/antioxidants-13-00712-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/489f/11200862/837065d7ef3c/antioxidants-13-00712-g003.jpg

相似文献

1
Emerging Roles of Xanthine Oxidoreductase in Chronic Kidney Disease.黄嘌呤氧化还原酶在慢性肾脏病中的新作用
Antioxidants (Basel). 2024 Jun 12;13(6):712. doi: 10.3390/antiox13060712.
2
Xanthine oxidoreductase: One enzyme for multiple physiological tasks.黄嘌呤氧化还原酶:一种酶,多种生理功能。
Redox Biol. 2021 May;41:101882. doi: 10.1016/j.redox.2021.101882. Epub 2021 Jan 27.
3
Chronic kidney disease: Which role for xanthine oxidoreductase activity and products?慢性肾脏病:黄嘌呤氧化还原酶活性和产物的作用是什么?
Pharmacol Res. 2022 Oct;184:106407. doi: 10.1016/j.phrs.2022.106407. Epub 2022 Aug 20.
4
Human Plasma Xanthine Oxidoreductase Activity in Cardiovascular Disease: Evidence from a Population-Based Study.心血管疾病中人类血浆黄嘌呤氧化还原酶活性:基于人群研究的证据。
Biomedicines. 2023 Mar 1;11(3):754. doi: 10.3390/biomedicines11030754.
5
Xanthine Oxidoreductase-Derived Reactive Species: Physiological and Pathological Effects.黄嘌呤氧化还原酶衍生的活性物质:生理和病理效应
Oxid Med Cell Longev. 2016;2016:3527579. doi: 10.1155/2016/3527579. Epub 2015 Dec 28.
6
New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity.代谢性疾病中嘌呤代谢的新见解:黄嘌呤氧化还原酶活性的作用。
Am J Physiol Endocrinol Metab. 2020 Nov 1;319(5):E827-E834. doi: 10.1152/ajpendo.00378.2020. Epub 2020 Sep 7.
7
Xanthine oxidoreductase in cancer: more than a differentiation marker.癌症中的黄嘌呤氧化还原酶:不仅仅是一种分化标志物。
Cancer Med. 2016 Mar;5(3):546-57. doi: 10.1002/cam4.601. Epub 2015 Dec 21.
8
Dispelling dogma and misconceptions regarding the most pharmacologically targetable source of reactive species in inflammatory disease, xanthine oxidoreductase.消除关于炎症性疾病中最具药物靶向性活性物质来源——黄嘌呤氧化还原酶的教条和误解。
Arch Toxicol. 2015 Aug;89(8):1193-207. doi: 10.1007/s00204-015-1523-8. Epub 2015 May 21.
9
Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications.黄嘌呤氧化还原酶与心血管疾病:分子机制及病理生理学意义
J Physiol. 2004 Mar 16;555(Pt 3):589-606. doi: 10.1113/jphysiol.2003.055913. Epub 2003 Dec 23.
10
Xanthine oxidoreductase-catalyzed reactive species generation: A process in critical need of reevaluation.黄嘌呤氧化还原酶催化的活性物质生成:一个急需重新评估的过程。
Redox Biol. 2013 Jun 10;1(1):353-8. doi: 10.1016/j.redox.2013.05.002.

引用本文的文献

1
Metabolic Reprogramming in Autosomal Dominant Polycystic Kidney Disease: Role in Cystogenesis and Novel Therapeutic Approaches.常染色体显性多囊肾病中的代谢重编程:在囊肿形成中的作用及新的治疗方法
Biomedicines. 2025 Jun 30;13(7):1596. doi: 10.3390/biomedicines13071596.
2
Association between uric acid to high-density lipoprotein cholesterol ratio and chronic kidney disease in Chinese patients with type 2 diabetes mellitus: a cross-sectional study.中国 2 型糖尿病患者尿酸与高密度脂蛋白胆固醇比值和慢性肾脏病的相关性:一项横断面研究
Front Nutr. 2025 Apr 14;12:1582495. doi: 10.3389/fnut.2025.1582495. eCollection 2025.
3

本文引用的文献

1
Kidney Failure Secondary to Hereditary Xanthinuria due to a Homozygous Deletion of the XDH Gene in the Absence of Overt Kidney Stone Disease.遗传性黄嘌呤尿症导致的肾脏衰竭,该疾病是由于 XDH 基因纯合缺失所致,且无明显肾脏结石病。
Nephron. 2024;148(8):578-583. doi: 10.1159/000536248. Epub 2024 Mar 25.
2
Gender Influence on XOR Activities and Related Pathologies: A Narrative Review.性别对黄嘌呤氧化还原酶活性及相关病理的影响:一项叙述性综述
Antioxidants (Basel). 2024 Feb 7;13(2):211. doi: 10.3390/antiox13020211.
3
Chronic kidney disease in a murine model of non-alcoholic steatohepatitis (NASH).
Association between RC/HDL-C and hyperuricemia in adults: evidence from NHANES 2005-2018.
成人中RC/HDL-C与高尿酸血症之间的关联:来自2005 - 2018年美国国家健康与营养检查调查(NHANES)的证据
Front Endocrinol (Lausanne). 2025 Feb 24;16:1514067. doi: 10.3389/fendo.2025.1514067. eCollection 2025.
4
Reactive Oxygen Species in Cystic Kidney Disease.多囊肾病中的活性氧物种
Antioxidants (Basel). 2024 Sep 30;13(10):1186. doi: 10.3390/antiox13101186.
非酒精性脂肪性肝炎(NASH)小鼠模型中的慢性肾脏病。
Kidney Int. 2024 Mar;105(3):540-561. doi: 10.1016/j.kint.2023.12.009. Epub 2023 Dec 28.
4
Past, present and future of xanthine oxidase inhibitors: design strategies, structural and pharmacological insights, patents and clinical trials.黄嘌呤氧化酶抑制剂的过去、现在与未来:设计策略、结构与药理学见解、专利及临床试验
RSC Med Chem. 2023 Aug 7;14(11):2155-2191. doi: 10.1039/d3md00316g. eCollection 2023 Nov 15.
5
Chronic kidney outcomes associated with GLP-1 receptor agonists versus long-acting insulins among type 2 diabetes patients requiring intensive glycemic control: a nationwide cohort study.2 型糖尿病患者强化血糖控制时 GLP-1 受体激动剂与长效胰岛素相关的慢性肾脏结局:一项全国性队列研究。
Cardiovasc Diabetol. 2023 Oct 4;22(1):272. doi: 10.1186/s12933-023-01991-5.
6
The Role of Uric Acid in Human Health: Insights from the Gene.尿酸在人类健康中的作用:来自该基因的见解。
J Pers Med. 2023 Sep 20;13(9):1409. doi: 10.3390/jpm13091409.
7
Mechanisms and rationale for uricase use in patients with gout.尿酸酶在痛风患者中的应用机制和原理。
Nat Rev Rheumatol. 2023 Oct;19(10):640-649. doi: 10.1038/s41584-023-01006-3. Epub 2023 Sep 8.
8
Multi-omics reveal mechanisms underlying chronic kidney disease of unknown etiology (CKDu) pathogenesis using zebrafish.多组学研究利用斑马鱼揭示了病因不明的慢性肾脏病(CKDu)发病机制的潜在机制。
Environ Pollut. 2023 Nov 15;337:122524. doi: 10.1016/j.envpol.2023.122524. Epub 2023 Sep 6.
9
Effects of febuxostat on markers of endothelial dysfunction and renal progression in patients with chronic kidney disease.非布司他对慢性肾脏病患者血管内皮功能障碍和肾脏进展标志物的影响。
Sci Rep. 2023 Aug 18;13(1):13494. doi: 10.1038/s41598-023-40767-5.
10
Discriminating Susceptibility of Xanthine Oxidoreductase Family to Metals.鉴别黄嘌呤氧化还原酶家族对金属的敏感性。
Microbiol Spectr. 2023 Aug 17;11(4):e0481422. doi: 10.1128/spectrum.04814-22. Epub 2023 Jul 17.